Loading viewer...
report
Format: PDF report
This report presents an update on the clinical activity of Resimmune, a targeted therapy for patients with Cutaneous T Cell Lymphomas (CTCL).
report
Deutsche Bank
report
Matas
report
Abbott Laboratories
report
Acidic company